Athyrium Capital Management, LP Amryt Pharma PLC Transaction History

Athyrium Capital Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 16, 2023	BUY	$7.0 - $14.77 $62 Million - $131 Million	8,857,268 New	8,857,268 $129 Million
Q1 2023 May 15, 2023	SELL	$7.0 - $14.77 $62 Million - $131 Million	-8,857,268 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$9.44 - $12.24 $40.9 Million - $53.1 Million	4,337,268 Added 95.96%	8,857,268 $95.7 Million
Q4 2020 Feb 16, 2021	BUY	$12.22 - $14.16 $55.2 Million - $64 Million	4,520,000 New	4,520,000 $64 Million

142K

Ticker AMYT
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 64,177,000
Description
Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with ...

Get notified when there are updates to the investment portfolio of Athyrium Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Athyrium Capital Management, LP with notifications on news.